Explore for biomarkers that are useful for detection of gastrointestinal cancer and prediction of therapeutic response of gastrointestinal cancer by analyzing circulating tumor DNA (ctDNA) and circulating tumor cells (CTC)

Explore for biomarkers that are useful for detection of gastrointestinal cancer and prediction of therapeutic response of gastrointestinal cancer by analyzing circulating tumor DNA (ctDNA) and circulating tumor cells (CTC) - Diagnosis of gastrointestinal cancer using liquid biopsy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017372

Enrollment

200

Registered

2015-05-01

Start date

2015-02-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal cancer (esophageal cancer, stomach cancer, colorectal cancer)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. patients with gastrointestinal cancer 2. patients with suspected gastrointestinal cancer

Exclusion criteria

Exclusion criteria: 1. patients with inherited colorectal cancer syndromes 2. patients with inflammatory bowel disease

Design outcomes

Primary

Measure	Time frame
Utility of biomarkers of gastrointestinal cancer	—

Countries

Japan

Contacts

Public ContactEiji Kubota

Nagoya City University Graduate School of Medical Sciences Department of Gastroenterology and Metabolism

ekubota@med.nagoya-cu.ac.jp052-851-5511

Outcome results